Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

32.65
-1.2900-3.80%
Volume:477.13K
Turnover:15.91M
Market Cap:4.18B
PE:-22.82
High:34.21
Open:34.21
Low:32.50
Close:33.94
52wk High:41.14
52wk Low:10.83
Shares:128.00M
Float Shares:112.00M
Volume Ratio:0.42
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:17.47
PE(LYR):-21.33

Loading ...

Dec 19, 2023

Correspondence

Form CORRESP - Correspondence
Dec 11, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Oct 14, 2023

Major Issues Report

Form 8-K - Current report
Oct 04, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 18, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 27, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
May 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities